Thermo Fisher Scientific在2025年第三季度的盈利预期中超预期，上调了2025年的财报指引，并宣布了股息，股价接近12个月高点。 Thermo Fisher Scientific beat earnings estimates in Q3 2025, raised 2025 guidance, and announced a dividend, with stock near 12-month high.

Themore Fisher Science报告说,10月22日Q3收入丰厚,有5.79 EPS和11.12亿美元的收入,超过估计。 Thermo Fisher Scientific reported strong Q3 earnings on October 22, with $5.79 EPS and $11.12 billion in revenue, surpassing estimates. 该公司提高了2025年EPS指南,宣布季度股息为0.43美元,收益率为0.3%。 The company raised its 2025 EPS guidance and announced a $0.43 quarterly dividend, yielding 0.3%. 机构投资者,包括Gladstone机构咨询和Geneos财富管理,调整了他们的利害关系,Gladstone的地位降低了32.1%。 Institutional investors, including Gladstone Institutional Advisory and Geneos Wealth Management, adjusted their stakes, with Gladstone reducing its position by 32.1%. 该股票于2026年1月8日以616.97美元关闭, 接近12个月的最高点, The stock closed at $616.97 on January 8, 2026, near its 12-month high, with a consensus "Moderate Buy" rating and a target of $621.70.